Human Mesenchymal Stem Cells Overexpressing Interleukin 2 Can Suppress Proliferation of Neuroblastoma Cells in Co-Culture and Activate Mononuclear Cells In Vitro
High-dose recombinant interleukin 2 (IL2) therapy has been shown to be successful in renal cell carcinoma and metastatic melanoma. However, systemic administration of high doses of IL2 can be toxic, causing capillary leakage syndrome and stimulating pro-tumor immune response. One of the strategies t...
Main Authors: | Daria S. Chulpanova, Valeriya V. Solovyeva, Victoria James, Svetlana S. Arkhipova, Marina O. Gomzikova, Ekaterina E. Garanina, Elvira R. Akhmetzyanova, Leysan G. Tazetdinova, Svetlana F. Khaiboullina, Albert A. Rizvanov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/7/2/59 |
Similar Items
-
Differentiation inducing effect of isoflavonoids on neuroblastoma cells
by: Tai, Lai Shan
Published: (1999) -
Apoptotic Cell Death in Neuroblastoma
by: Akira Nakagawara, et al.
Published: (2013-06-01) -
Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
by: Daria S. Chulpanova, et al.
Published: (2018-03-01) -
Interaction of bone marrow-derived mesenchymal stem cells on neuroblastoma cells
by: Kwong, Rebecca Sze-Wai.
Published: (2013) -
Visualization and characterization of cell surface glycoproteins on mouse neuroblastoma cells
by: Maher, Pamela A.
Published: (2010)